NCT01373931View on ClinicalTrials.gov

A Study of LY2216684 in Healthy Females

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Depressive Disorder, Major
Interventions
DRUG

LY2216684

Administered orally

DRUG

Ortho Cyclen

35 micrograms (mcg) ethinyl estradiol and 250 mcg norgestimate administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY